Viewing StudyNCT00077467



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00077467
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2004-02-10

Brief Title: Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Recurrent Childhood Acute Myeloid Leukemia
Blastic Phase Chronic Myelogenous Leukemia
Childhood Acute Promyelocytic Leukemia M3
Recurrent Childhood Acute Lymphoblastic Leukemia
Keywords: